Cargando…
Impact of BSE on the biotechnology industry — detection and risk assessment
This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148827/ http://dx.doi.org/10.1016/S0958-2118(04)00238-1 |
| _version_ | 1783520678469697536 |
|---|---|
| author | Atkinson, Simon |
| author_facet | Atkinson, Simon |
| author_sort | Atkinson, Simon |
| collection | PubMed |
| description | This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion. |
| format | Online Article Text |
| id | pubmed-7148827 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71488272020-04-13 Impact of BSE on the biotechnology industry — detection and risk assessment Atkinson, Simon Membrane Technology Article This feature briefly looks at filtration technologies that are being developed by Pall Corp to reduce the potential risk of ‘Mad Cow Disease’ in biological products and drugs. It also provides details of proprietary technology that is designed to reduce prions from blood prior to a transfusion. Elsevier Ltd. 2004-10 2004-10-30 /pmc/articles/PMC7148827/ http://dx.doi.org/10.1016/S0958-2118(04)00238-1 Text en Copyright © 2004 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Atkinson, Simon Impact of BSE on the biotechnology industry — detection and risk assessment |
| title | Impact of BSE on the biotechnology industry — detection and risk assessment |
| title_full | Impact of BSE on the biotechnology industry — detection and risk assessment |
| title_fullStr | Impact of BSE on the biotechnology industry — detection and risk assessment |
| title_full_unstemmed | Impact of BSE on the biotechnology industry — detection and risk assessment |
| title_short | Impact of BSE on the biotechnology industry — detection and risk assessment |
| title_sort | impact of bse on the biotechnology industry — detection and risk assessment |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148827/ http://dx.doi.org/10.1016/S0958-2118(04)00238-1 |
| work_keys_str_mv | AT atkinsonsimon impactofbseonthebiotechnologyindustrydetectionandriskassessment |